S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
NASDAQ:REGN

Regeneron Pharmaceuticals Short Interest Ratio and Short Volume

$635.16
+1.16 (+0.18%)
(As of 12/3/2021 04:00 PM ET)
Add
Compare
Today's Range
$623.12
$641.79
50-Day Range
$543.48
$654.40
52-Week Range
$441.00
$686.62
Volume
649,654 shs
Average Volume
847,466 shs
Market Capitalization
$68.31 billion
P/E Ratio
10.14
Dividend Yield
N/A
Beta
0.19

Regeneron Pharmaceuticals (NASDAQ:REGN) Short Interest Data

Current Short Volume
1,610,000 shares
Previous Short Volume
1,880,000 shares
Change Vs. Previous Month
-14.36%
Dollar Volume Sold Short
$1.04 billion
Short Interest Ratio / Days to Cover
2.1
Last Record Date
November, 15 2021
Outstanding Shares
107,543,000 shares
Float Size
102,810,000 shares
Short Percent of Float
1.57%
Today's Trading Volume
649,654 shares
Average Trading Volume
847,466 shares
Today's Volume Vs. Average
-23.34%
Skip Charts & View Short Interest History

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Regeneron Pharmaceuticals ?

Sign up to receive the latest short interest report for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Regeneron Pharmaceuticals (NASDAQ:REGN) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/15/20211,610,000 shares $1.04 billion -14.4%1.6%2.1 $647.73
10/29/20211,880,000 shares $1.20 billion +6.8%1.8%2.3 $639.94
10/15/20211,760,000 shares $973.70 million -2.2%1.7%2.2 $553.24
9/30/20211,800,000 shares $1.09 billion +14.7%1.8%2.4 $605.18
9/15/20211,570,000 shares $1.02 billion +15.4%1.5%2 $652.00
8/31/20211,360,000 shares $915.82 million -3.6%1.3%1.7 $673.40
8/13/20211,410,000 shares $880.95 million -11.3%1.4%1.8 $624.79
7/30/20211,590,000 shares $913.63 million -13.6%1.6%2.1 $574.61
7/15/20211,840,000 shares $1.08 billion +30.5%1.8%2.4 $589.32
6/30/20211,410,000 shares $787.54 million -26.6%1.4%1.8 $558.54
6/15/20211,920,000 shares $1.01 billion -9.0%1.9%2.4 $527.49
5/28/20212,110,000 shares $1.06 billion -5.4%2.1%2.6 $502.43
5/14/20212,230,000 shares $1.15 billion -4.7%2.2%2.6 $517.17
4/30/20212,340,000 shares $1.13 billion -14.9%2.3%2.5 $485.00
4/15/20212,750,000 shares $1.32 billion +24.4%2.7%2.8 $481.16
3/31/20212,210,000 shares $1.04 billion -16.9%2.2%2.1 $470.67
3/15/20212,660,000 shares $1.25 billion +14.7%2.6%2.6 $471.46
2/26/20212,320,000 shares $1.05 billion +10.0%2.3%2.2 $453.19
2/12/20212,110,000 shares $1.04 billion +8.8%2.1%2 $490.54
1/29/20211,940,000 shares $982.16 million -18.8%1.9%2 $506.27
1/15/20212,390,000 shares $1.24 billion +6.2%2.4%2.6 $517.91
12/31/20202,250,000 shares $1.08 billion +14.8%2.2%2.4 $478.30
12/15/20201,960,000 shares $980.74 million -8.0%1.9%1.9 $500.38
11/30/20202,130,000 shares $1.09 billion +6.0%2.1%2.2 $514.05
11/15/20202,010,000 shares $1.14 billion -7.4%2.0%2.1 $566.43

Institutional Investors Shorting Regeneron Pharmaceuticals (NASDAQ:REGN)

This table shows institutional investors, funds, and major shareholders that have reported short positions as of their most recent reporting period. Most commonly, these investors have purchased put options on shares of Regeneron Pharmaceuticals. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Reporting DateInvestor NameShares Shorted (Previous)Shares Shorted (Current)Position ChangePosition Size
12/1/2021Balyasny Asset Management LLC1,6000-100.0%$0.00
11/16/2021BNP Paribas Arbitrage SA432432No Change$26.14 thousand
11/16/2021Jane Street Group LLC84,50095,900+13.5%$58.04 thousand
11/16/2021Squarepoint Ops LLC5,0005,300+6.0%$3.21 thousand
11/16/2021Two Sigma Investments LP27,30021,900-19.8%$13.25 thousand
11/16/2021Two Sigma Securities LLC700800+14.3%$484.00
11/16/2021UBS Group AG75,41382,613+9.5%$50.00 thousand
11/16/2021Millennium Management LLC129,000286,600+122.2%$173.45 thousand
11/16/2021Citadel Advisors LLC337,500392,800+16.4%$237.72 thousand
11/15/2021Point72 Hong Kong Ltd5,1005,200+2.0%$3.15 thousand
11/15/2021Marshall Wace LLPN/A2,300N/A$1.39 thousand
11/15/2021Capstone Investment Advisors LLC57,00067,000+17.5%$40.55 thousand
11/15/2021Balyasny Asset Management LLC1,6000-100.0%$0.00
11/15/2021Caas Capital Management LP2,0002,000No Change$1.21 thousand
11/12/2021PEAK6 Investments LLC60,76498,100+61.4%$59.37 thousand
11/12/2021Hsbc Holdings PLC5,0004,900-2.0%$2.99 thousand
11/12/2021Credit Suisse AG18,50014,800-20.0%$8.96 thousand
11/12/2021Wolverine Trading LLC40,10033,200-17.2%$20.14 thousand
11/10/2021Goldman Sachs Group Inc.N/A8,600N/A$5.21 thousand
11/10/2021HAP Trading LLC23,90021,600-9.6%$156.00
11/10/2021Allianz Asset Management GmbH2,0004,100+105.0%$2.48 thousand
11/10/2021Citigroup Inc.35,50040,500+14.1%$24.51 thousand
11/9/2021Concourse Financial Group Securities Inc.N/A0N/A$0.00
11/5/2021IMC Chicago LLC25,40041,700+64.2%$25.24 thousand
10/28/2021Simplex Trading LLC25,00025,900+3.6%$14.88 thousand
9/13/2021Bank of America Corp DE97,40045,400-53.4%$25.36 thousand













Regeneron Pharmaceuticals (NASDAQ:REGN) Short Interest Frequently Asked Questions

What is Regeneron Pharmaceuticals' current short interest?

Short interest is the volume of Regeneron Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of November 15th, investors have sold 1,610,000 shares of REGN short. 1.57% of Regeneron Pharmaceuticals' shares are currently sold short. Learn More on Regeneron Pharmaceuticals' current short interest.

What is a good short interest ratio for Regeneron Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Regeneron Pharmaceuticals currently has a short interest ratio of 2.0. Learn More on a good short interest ratio for Regeneron Pharmaceuticals

Which institutional investors are shorting Regeneron Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Regeneron Pharmaceuticals: Balyasny Asset Management LLC, BNP Paribas Arbitrage SA, Jane Street Group LLC, Squarepoint Ops LLC, Two Sigma Investments LP, Two Sigma Securities LLC, UBS Group AG, Millennium Management LLC, Citadel Advisors LLC, Point72 Hong Kong Ltd, Marshall Wace LLP, Capstone Investment Advisors LLC, Balyasny Asset Management LLC, Caas Capital Management LP, PEAK6 Investments LLC, Hsbc Holdings PLC, Credit Suisse AG, Wolverine Trading LLC, Goldman Sachs Group Inc., HAP Trading LLC, Allianz Asset Management GmbH, Citigroup Inc., Concourse Financial Group Securities Inc., IMC Chicago LLC, Simplex Trading LLC, and Bank of America Corp DE. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Regeneron Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.57% of Regeneron Pharmaceuticals' floating shares are currently sold short.

Is Regeneron Pharmaceuticals' short interest increasing or decreasing?

Regeneron Pharmaceuticals saw a decrease in short interest in the month of November. As of November 15th, there was short interest totaling 1,610,000 shares, a decrease of 14.4% from the previous total of 1,880,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Regeneron Pharmaceuticals' float size?

Regeneron Pharmaceuticals currently has issued a total of 107,543,000 shares. Some of Regeneron Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Regeneron Pharmaceuticals currently has a public float of 102,810,000 shares.

How does Regeneron Pharmaceuticals' short interest compare to its competitors?

1.57% of Regeneron Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sub-industry of "biotechnology" compare to Regeneron Pharmaceuticals: Amgen Inc. (2.07%), Gilead Sciences, Inc. (0.00%), Vertex Pharmaceuticals Incorporated (1.15%), Biogen Inc. (1.40%), Seagen Inc. (1.80%), Alnylam Pharmaceuticals, Inc. (0.00%), BioMarin Pharmaceutical Inc. (5.57%), Incyte Co. (2.50%), Repligen Co. (3.22%), and Exact Sciences Co. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($11.06 billion), S&P Global Inc. ($8.74 billion), Charter Communications, Inc. ($5.66 billion), Canadian Pacific Railway Limited ($5.43 billion), Wayfair Inc. ($4.23 billion), Palo Alto Networks, Inc. ($3.46 billion), DoorDash, Inc. ($3.41 billion), Teladoc Health, Inc. ($2.84 billion), Etsy, Inc. ($2.76 billion), and Zscaler, Inc. ($2.62 billion). View all of the most shorted stocks.

What does it mean to sell short Regeneron Pharmaceuticals stock?

Short selling REGN is an investing strategy that aims to generate trading profit from Regeneron Pharmaceuticals as its price is falling. Regeneron Pharmaceuticals' stock is trading up $1.16 today. To short Regeneron Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Regeneron Pharmaceuticals will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Regeneron Pharmaceuticals?

A short squeeze for Regeneron Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of REGN, which in turn drives the price of the stock up even further.

How often is Regeneron Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including REGN, twice per month. The most recent reporting period available is November, 15 2021.



This page was last updated on 12/5/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.